BioInvent International AB (OSTO:BINV) Other Current Receivables : kr0.00 Mil (As of Mar. 2024)

View and export this data going back to 2001. Start your Free Trial

What is BioInvent International AB Other Current Receivables?

BioInvent International AB's Other Current Receivables for the quarter that ended in Mar. 2024 was kr0.00 Mil.

BioInvent International AB's annual Other Current Receivables increased from Dec. 2021 (kr9.02 Mil) to Dec. 2022 (kr24.19 Mil) and increased from Dec. 2022 (kr24.19 Mil) to Dec. 2023 (kr27.76 Mil).

BioInvent International AB Other Current Receivables Historical Data

The historical data trend for BioInvent International AB's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioInvent International AB Other Current Receivables Chart

BioInvent International AB Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Current Receivables

Get a 7-Day Free Trial

17.15

5.55

9.02

24.19

27.76

BioInvent International AB Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Current Receivables	Get a 7-Day Free Trial															-	-	-	27.76	-

BioInvent International AB Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

BioInvent International AB Other Current Receivables Related Terms

Thank you for viewing the detailed overview of BioInvent International AB's Other Current Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

BioInvent International AB (OSTO:BINV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BioInvent International AB (OSTO:BINV) » Definitions » Other Current Receivables

Comparable Companies

Traded in Other Exchanges

0H22:UK BIX:Germany

Address

Ideongatan 1, The Gamma Building, Lund, SWE, SE-223 70

Website

https://www.bioinvent.com

BioInvent International AB is a clinical-stage biotech company. It discovers and develops novel and first-in-class immuno-modulatory antibodies for cancer therapy, with currently four drug candidates in five ongoing clinical programs in Phase 1/2 trials for the treatment of hematological cancer and solid tumors, respectively. The company's validated, proprietary F.I.R.S.T technology platform identifies both targets and the antibodies that bind to them, generating many new drug candidates to fuel the company's own clinical development pipeline and providing licensing and partnering opportunities. The company's pipeline portfolio comprises BI-1206, an antagonistic blocking antibody for the treatment of non-Hodgkin's lymphoma, and BI-1808 and BI-1910 (anti-TNFR2) for solid cancers.

BioInvent International AB (OSTO:BINV) Headlines

No Headlines